NASDAQ:CYCC
Cyclacel Pharmaceuticals Stock News
$1.96
+0.0400 (+2.08%)
At Close: Mar 27, 2024
Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
06:09pm, Tuesday, 19'th Mar 2024
Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Wednesday, 13'th Mar 2024
BERKELEY HEIGHTS, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference
09:15am, Tuesday, 20'th Feb 2024
BERKELEY HEIGHTS, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative m
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today?
09:07am, Tuesday, 09'th Jan 2024
Cyclacel Pharmaceuticals (NASDAQ: CYCC ) stock is falling on Tuesday but it's not due to any negative news from the clinical-stage biopharmaceutical company. Instead, shares of CYCC stock are retreat
Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024
09:15am, Tuesday, 02'nd Jan 2024
BERKELEY HEIGHTS, N.J., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative m
Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results
09:15am, Tuesday, 07'th Nov 2023
BERKELEY HEIGHTS, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative m
New Strong Buy Stocks for October 17th
08:16am, Tuesday, 17'th Oct 2023
MNTX, PGNY, GFF, RKDA and CYCC have been added to the Zacks Rank #1 (Strong Buy) List on October 17, 2023.
Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Results
09:15am, Thursday, 03'rd Aug 2023
BERKELEY HEIGHTS, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative m
Cyclacel Pharmaceuticals Inc. (CYCC) Q1 2023 Earnings Call Transcript
07:59pm, Thursday, 11'th May 2023
Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC ) Q1 2023 Results Conference Call May 11, 2023 4:30 PM ET Company Participants Grace Kim - IR Spiro Rombotis - CEO Mark Kirschbaum - CMO Paul McBarron - CFO
Cyclacel Pharmaceuticals to Release First Quarter 2023 Financial Results
09:15am, Thursday, 04'th May 2023
BERKELEY HEIGHTS, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative me
Cyclacel Pharmaceuticals to Participate in March Investor Conferences
09:15am, Tuesday, 07'th Mar 2023
BERKELEY HEIGHTS, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative
Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2022 Earnings Call Transcript
09:04pm, Monday, 06'th Mar 2023
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC ) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ET Company Participants Irina Koffler - Investor Relations Spiro Rombotis - President and Chief Exe
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2022 Financial Results
02:15pm, Monday, 27'th Feb 2023 GlobeNewswire Inc.
BERKELEY HEIGHTS, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2022 Financial Results
09:15am, Monday, 27'th Feb 2023
BERKELEY HEIGHTS, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative m
Cyclacel Pharmaceuticals to Participate in the 2023 BIO CEO & Investor Conference
02:15pm, Monday, 30'th Jan 2023 GlobeNewswire Inc.
BERKELEY HEIGHTS, N.J., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative